Proteomics

Dataset Information

0

T. brucei whole cell proteome changes upon exposure to the experimental phthalimide-based trypanocidal drug PHT-39


ABSTRACT: In a phenotypic screening approach of novel molecules composed of a synergistic combination of phthalimide, benzimidazole, and triazole scaffolds we discovered compounds with potent anti-leishmanial activity. The resulting early-lead compound PHT-39, which contains a trifluoromethyl substitution, demonstrated the highest efficacy in a Leishmania infantum intramacrophage assay, with an EC50 of 1.2 +/- 3.2 μM.Cytotoxicity testing of PHT-39 in Hep-G2 cells indicated high selectivity of over 90-fold. To investigate the mechanism of action we carried out experiments in Trypanosoma brucei, which is also sensitive to PHT-39. Here we used liquid chromatography coupled with tandem mass spectrometry (LC-MSMS) to quantify the effects of PH-39 exposure on the global protein landscape in T. brucei.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Trypanosoma Brucei

TISSUE(S): Permanent Cell Line Cell, Cell Culture

DISEASE(S): Trypanosomiasis

SUBMITTER: Martin Zoltner  

LAB HEAD: Martin Zoltner

PROVIDER: PXD043204 | Pride | 2024-03-12

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
1097-ph1.raw Raw
1097-ph2.raw Raw
1097-ph3.raw Raw
1097-tc1.raw Raw
1097-tc2.raw Raw
Items per page:
1 - 5 of 8

Similar Datasets

2024-03-08 | E-MTAB-13844 | biostudies-arrayexpress
2024-03-25 | PXD049328 | Pride
2024-03-25 | PXD050946 | Pride
2023-06-14 | PXD042322 | Pride
2023-03-11 | PXD031887 | Pride
2012-05-29 | E-GEOD-37593 | biostudies-arrayexpress
2023-06-14 | PXD038550 | Pride
2024-03-25 | PXD042022 | Pride
2023-12-04 | PXD047268 | Pride
2022-11-30 | PXD031245 | Pride